Variant report
Variant | esv2587098 |
---|---|
Chromosome Location | chr12:8624940-8626654 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:8625872..8627990-chr12:8629712..8631446,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142553353 | chr12:8624943-8624944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537910650 | chr12:8624949-8624950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554188720 | chr12:8625081-8625082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577259990 | chr12:8625082-8625083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546217891 | chr12:8625133-8625134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376546666 | chr12:8625204-8625205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370123765 | chr12:8625247-8625248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562853426 | chr12:8625294-8625295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs202070610 | chr12:8625593-8625594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs532071854 | chr12:8625869-8625870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12321576 | chr12:8625870-8625871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200064030 | chr12:8625887-8625888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201215747 | chr12:8625888-8625889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201702280 | chr12:8625889-8625890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376226774 | chr12:8625993-8625994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72621031 | chr12:8626008-8626009 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs114070724 | chr12:8626040-8626041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs114623774 | chr12:8626080-8626081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115368803 | chr12:8626091-8626092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146744618 | chr12:8626098-8626099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373625839 | chr12:8626137-8626138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116272019 | chr12:8626184-8626185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115383256 | chr12:8626227-8626228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140301417 | chr12:8626249-8626250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367719413 | chr12:8626276-8626277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200365843 | chr12:8626318-8626319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4334073 | chr12:8626362-8626363 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs181967141 | chr12:8626377-8626378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372897340 | chr12:8626442-8626443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186504433 | chr12:8626464-8626465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547672231 | chr12:8626510-8626511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190450879 | chr12:8626538-8626539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114433130 | chr12:8626594-8626595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Epilepsy | 21858020 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Alzheimer''s disease | 17160897 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:8624600-8625200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr12:8624600-8625200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr12:8624800-8625000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr12:8624800-8625200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr12:8624800-8625200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr12:8624800-8625200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr12:8625000-8625600 | Enhancers | Primary monocytes fromperipheralblood | blood |
8 | chr12:8625000-8627800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr12:8625200-8625600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr12:8625200-8627600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr12:8625200-8627800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr12:8625200-8628000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr12:8625200-8628000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr12:8625200-8628000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr12:8626200-8627800 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
16 | chr12:8626600-8628000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |